Status:
ACTIVE_NOT_RECRUITING
The National Lipedema Study
Lead Sponsor:
Haraldsplass Deaconess Hospital
Collaborating Sponsors:
St. Olavs Hospital
University Hospital of North Norway
Conditions:
Lipedema
Eligibility:
FEMALE
20-65 years
Phase:
NA
Brief Summary
Lipedema is a chronic condition with a symmetrical accumulation of painful fatty tissue primarily affecting the limbs, sparing hands, feet and trunk. The subcutaneous fatty tissue is disproportionatel...
Eligibility Criteria
Inclusion
- female
- age 20-65 years
- significant pain from lipedema
- lipedema stage 1-2 or localized stage 3
Exclusion
- Non-fluency in the Norwegian language
- pregnancy
- current malignancy
- previous surgical treatment for lipedema
- smoking
- BMI \> 28
- serious comorbidities such as cardiac-, pulmonary-, renal disease
- unwillingness to wear compression garments
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT05284266
Start Date
March 11 2022
End Date
December 31 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haraldsplass Deaconess Hospital
Bergen, Norway, 5009